We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

6 hedge funds and large institutions have $53.1K invested in China Pharma Holdings in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

0.06% less ownership

Funds ownership: 0.09% → 0.03% (-0.06%)

43% less capital invested

Capital invested by funds: $92.7K → $53.1K (-$39.7K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
+$7.49K
2
TSS
Two Sigma Securities
New York
+$6.75K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$37.4K
2
Millennium Management
Millennium Management
New York
-$5.96K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$22K -$37.4K -2,130 -63%
Millennium Management
2
Millennium Management
New York
$12.5K -$5.96K -339 -32%
VF
3
Virtu Financial
New York
$7K +$7.49K +426 New
TSS
4
Two Sigma Securities
New York
$6.55K +$6.75K +384 New
BCM
5
Bridgeway Capital Management
Texas
$4.95K – – –
FCT
6
First Community Trust
Iowa
$51 – – –

CPHI Hedge Fund Activity: Q2 2023 in Review

6 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2023, worth a combined $53.1K — down 43% from $92.7K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CPHI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $7.49K. The largest seller was Renaissance Technologies, cutting an estimated $37.4K.

  • 6 institutional investors held China Pharma Holdings (CPHI) as of Q2 2023, up from 4 in Q1 2023.
  • Funds reported $53.1K of China Pharma Holdings stock for Q2 2023, down 43% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q2 2023 and 0 closed out, a net change of +2 holders.
  • The largest China Pharma Holdings buyer in Q2 2023 was Virtu Financial, an estimated $7.49K added.
  • The largest China Pharma Holdings seller in Q2 2023 was Renaissance Technologies, an estimated $37.4K sold.

Based on aggregated 13F filings for Q2 2023.